CYTOKINE EXPRESSION IN LABIAL SALIVARY-GLANDS FROM PATIENTS WITH PRIMARY SJOGRENS-SYNDROME

被引：70

作者：

OXHOLM, P

DANIELS, TE

BENDTZEN, K

机构：

[1] Division of Oral Pathology, Department of Stomatology, University of California, San Francisco, CA

[2] Laboratory of Medical Immunology TA, Rigshospitalet, State University Hospital, DK-2200, Copenhagen N

来源：

AUTOIMMUNITY | 1992年 / 12卷 / 03期

关键词：

CYTOKINES; SALIVARY GLANDS; SJOGRENS SYNDROME;

D O I：

10.3109/08916939209148458

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The presence and distribution of 7 cytokines was examined immunohistologically in labial salivary gland (LSG) specimens from patients with primary Sögren's syndrome (SS) and control subjects. The cytokines interleukin (IL)-1βIL-6, tumor necrosis factor (TNF)α and interferon (IFN)γ were identified in defined parts of LSG from patients but not in the corresponding parts of control glands: (a) LSG acinar epithelium expressed IL-1β (b) blood vessels located in both normal LSG stroma and within lymphocytic infiltrates expressed IL-lβ IL-6 and IFNμ, and (c) lymphocytic infiltrates expressed IL-lβ IL-6 and TNFα All four cytokines were expressed by salivary ducts within both patient and control specimens, but with generally greater intensity in patients. IL-lα IL-4 and TNFβ (lymphotoxin) could not be detected in any of the specimens from patients or controls. The locations of cytokines in LSG suggests possible mechanisms of immunologically mediated parenchymal damage in primary SS. © 1992 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：185 / 191

页数：7

共 33 条

[21] Oxholm A., Oxholm P., Staberg B., Bendtzen K., Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment, Acta Dermato-Venereol, 69, pp. 195-199, (1989)
[22] Oxholm A., Oxholm P., Permin H., Bendtzen K., Epidermal tumour necrosis factor and interleukin 6-like activities in AlDS-related Kaposi's sarcoma. An immunohistological study, APMIS, 97, pp. 533-538, (1989)
[23] Oxholm A., Oxholm P., Staberg B., Bendtzen K., Expression of inlerleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903), Acta Dermato-Venereol, 69, pp. 385-390, (1989)
[24] Tabibzadeh S.S., Poubouridis D., May L.T., Sehgal P.B., Inter-leukin-6 immunoreactivity in human tumors, Am J Pathol, 135, pp. 427-433, (1989)
[25] McCall J.L., Yun K., Funamoto S., Parry B.R., vivo immuno-hislochemical identification of tumor necrosis factor/cachectin in human lymphoid tissue, Am J Pathol, 135, pp. 421-425, (1989)
[26] Ruco L.P., Stoppacciaro A., Pomponi D., Boraschi D., Santoni A., Tagliabue A., Et al., Immunoreactivity for IL-lβ and TNFα in human lymphoid and nonlymphoid tissues, Am J Pathol, 135, pp. 889-897, (1989)
[27] Daniels T.E., Talal N., Diagnosis and differential diagnosis of Sjögren's syndrome, Sjögren's Syndrome. Clinical and Immunological Aspects, pp. 193-199, (1987)
[28] Daniels T.E., Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases, Arthritis Rheum, 27, pp. 147-156, (1984)
[29] Harboe N.M.G., Ingild A., Immunization, isolation of immunoglobulins and antibody titre determination, Scand J Immunol, 17, pp. 345-351, (1983)
[30] Oxholm A., Diamant M., Oxholm P., Bendtzen K., Interleukin-6 and tumour necrosis factor a are expressed on keratinocytes but not on Langerhans cells, APMIS, 99, pp. 58-64, (1991)

← 1 2 3 4 →